Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value ($000): $234,139 (100.0% shares, 0.0% debt)

Holdings (14)

BBIO BridgeBio (BBIO) 44.2%

Value ($000) $103,449 Shares 3,835,722 Est. Cost $27.26 Unrealized 0.0%

— Eidos Therapeutics, Inc. (EIDIX) 14.9%

Value ($000) $34,922 Shares 1,123,630 Est. Cost $13.76 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 6.8%

Value ($000) $15,840 Shares 2,000,000 Est. Cost $5.55 Unrealized —

— ObsEva SA (OBSV) 6.7%

Value ($000) $15,679 Shares 1,386,338 Est. Cost $12.66 Unrealized —

— AVROBIO, Inc. (AVRO) 5.6%

Value ($000) $13,203 Shares 811,998 Est. Cost $17.15 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. (BHVN) 5.1%

Value ($000) $12,021 Shares 274,513 Est. Cost $36.98 Unrealized —

— Aeglea Biotherapeutics Inc (AGLE) 3.8%

Value ($000) $8,844 Shares 1,291,151 Est. Cost $7.61 Unrealized —

— Atreca (BCEL) 3.1%

Value ($000) $7,303 Shares 387,653 Est. Cost $18.84 Unrealized —

— Zosano Pharma Corporation (ZSAN) 2.8%

Value ($000) $6,633 Shares 2,028,571 Est. Cost $2.36 Unrealized —

— Sunesis Pharmaceuticals, Inc. (SNSS) 2.4%

Value ($000) $5,548 Shares 7,600,000 Est. Cost $0.94 Unrealized —

— Nabriva Therapeutics plc (NBRV) 1.9%

Value ($000) $4,396 Shares 1,809,259 Est. Cost $1.46 Unrealized —

RCUS Arcus Biosciences, Inc. (RCUS) 1.1%

Value ($000) $2,650 Shares 333,333 Est. Cost $11.67 Unrealized -14.2%

— Verona Pharma plc (VRNA) 1.0%

Value ($000) $2,262 Shares 443,596 Est. Cost $9.65 Unrealized —

ACRS Aclaris Theraputics Inc (ACRS) 0.6%

Value ($000) $1,389 Shares 634,455 Est. Cost $10.31 Unrealized -47.1%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio (BBIO)	3,835,722	$103,449	44.2%	$27.26	0.0%	COM	10806X102
—	Eidos Therapeutics, Inc. (EIDIX)	1,123,630	$34,922	14.9%	$13.76	—	COM	28249H104
—	Marker Therapeutics, Inc. (MRKR)	2,000,000	$15,840	6.8%	$5.55	—	COM	57055L107
—	ObsEva SA (OBSV)	1,386,338	$15,679	6.7%	$12.66	—	COM	H5861P103
—	AVROBIO, Inc. (AVRO)	811,998	$13,203	5.6%	$17.15	—	COM	05455M100
—	Biohaven Pharmaceutical Holding Company Ltd. (BHVN)	274,513	$12,021	5.1%	$36.98	—	COM	G11196105
—	Aeglea Biotherapeutics Inc (AGLE)	1,291,151	$8,844	3.8%	$7.61	—	COM	00773J103
—	Atreca (BCEL)	387,653	$7,303	3.1%	$18.84	—	CL A COM	04965G109
—	Zosano Pharma Corporation (ZSAN)	2,028,571	$6,633	2.8%	$2.36	—	COM	98979H202
—	Sunesis Pharmaceuticals, Inc. (SNSS)	7,600,000	$5,548	2.4%	$0.94	—	COM	867328700
—	Nabriva Therapeutics plc (NBRV)	1,809,259	$4,396	1.9%	$1.46	—	SHS	G63637105
RCUS	Arcus Biosciences, Inc. (RCUS)	333,333	$2,650	1.1%	$11.67	-14.2%	COM	03969F109
—	Verona Pharma plc (VRNA)	443,596	$2,262	1.0%	$9.65	—	COM	925050106
ACRS	Aclaris Theraputics Inc (ACRS)	634,455	$1,389	0.6%	$10.31	-47.1%	COM	00461U105